A new Nature paper suggests common variants in GLP1R and GIPR influence weight loss and nausea or vomiting, but the effects are modest, and non-genetic factors such as drug choice, dose, duration, sex, diabetes status, and tolerability still matter greatly
Always talk to your healthcare provider before combining therapies
Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6
Purpose-built for physicians Use of GLP-1 agonists prior to THA may increase postoperative nausea, vomiting Key takeaways: Postoperative nausea and vomiting occurred in 18.2% of patients prescribed GLP-1s vs
A meta-analysis of 80 000 patients found GLP-1 RAs were not associated with an increased risk of optic nerve/vision-threatening events [11], and a recent clinical trial of people taking the highest dose of semaglutide demonstrated excellent safety, increased muscle strength and an increased ratio of lean mass relative to total body mass in people taking semaglutide [12]
If small particles remain, set the vial down for 5 minutes and swirl again
